 Home > Biochemistry News > Biotechnology News > Amgen and Arrakis Therapeutics collaborate to develop small molecules to target RNA degradation

Amgen and Arrakis Therapeutics collaborate to develop small molecules to target RNA degradation

 Last Update: 2022-02-23
 Source: Internet
 Author: User

Tags

related companies logo

hum vitamins target

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On January 11, 2022, Amgen and Arrakis Therapeutics announced a research collaboration to discover and develop RNA-degrading therapeutics for a range of difficult-to-drug targets across multiple therapeutic areas

Most of the drugs currently developed for protein targets target a few types of proteins (such as receptor proteins)

Arrakis is taking multiple approaches to establish a new paradigm for small molecule drug discovery targeting multiple mechanisms of the RNA life cycle

▲Schematic diagram of Arrakis' RNA-targeting small molecule drug platform (Image source: Arrakis authorized to use)

The Induced Proximity Platform, which Amgen has established, enables the development of multispecific molecules

Under the terms of the agreement, Arrakis will be responsible for research activities to discover small-molecule compounds that bind to RNA against a broad range of targets nominated by Amgen

References

[1] AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA DEGRADER SMALL MOLECULE THERAPEUTICS.

(Original abridged)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.